Guide to using AAV vectors in gene therapy
Drug Discovery World
FEBRUARY 8, 2024
The event aimed to help the audience understand the AAV workflow, from upstream methods for AAV production and validation to downstream analysis of the packaged product for enhanced therapeutic development. Dr O’Hara also provided an AAV plasmid preparation case study. Why are those important?
Let's personalize your content